XINGANJIANG
873167
Sichuan Goldstone
300434
Hangzhou Huasu Technology
301157
Suzhou Harmontronics Automation Technology
688022
Xinjiang Tianshan Animal Husbandry Bio-engineering
300313
CN Stock MarketDetailed Quotes
688163 Shanghai Serum Bio-Technology
- 16.89
- +0.01+0.06%
Trading Jan 6 10:43 CST
1.83BMarket Cap35.86P/E (TTM)
17.03High16.38Low4.88KlotVolume16.89Open16.88Pre Close8.17MTurnover1.10%Turnover Ratio47.18P/E (Static)108.22MShares22.9252wk High1.64P/B749.44MFloat Cap10.6652wk Low20.26Limit Up44.37MShs Float61.02Historical High13.50Limit Down3.85%Amplitude10.66Historical Low0.32Dividend TTM16.73Avg Price2.72KlotAsk1.89%Div YieldTTM100Lot Size2.04KlotBid
Shanghai Serum Bio-Technology Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 72.43%210.36M | 65.90%172.34M | -4.50%124.09M | -70.74%150.92M | 8.07%122M | -77.19%103.88M | -29.62%129.95M | 345.07%515.73M | 20.53%112.89M | 700.19%455.42M |
| Transactional financial assets | -13.67%641.5M | -10.55%651.97M | -7.91%722.26M | 73.03%722.59M | -9.07%743.12M | 65.43%728.84M | 1.82%784.26M | 541.02%417.62M | 918.68%817.24M | 608.78%440.59M |
| Notes receivable and accounts receivable | 35.02%57.99M | 14.20%59.48M | 114.18%38.5M | 194.73%22.63M | 95.53%42.95M | 77.64%52.08M | -27.47%17.97M | -19.90%7.68M | 14.98%21.96M | -31.45%29.32M |
| -Accounts receivable | 35.02%57.99M | 14.20%59.48M | 114.18%38.5M | 194.73%22.63M | 95.53%42.95M | 77.64%52.08M | -27.47%17.97M | -19.90%7.68M | 14.98%21.96M | -31.45%29.32M |
| Other receivables (including interest and dividends) | 66.17%1.77M | -48.09%520.06K | 9.13%1.11M | -27.50%712.42K | -16.19%1.07M | -4.25%1M | -51.06%1.02M | -84.28%982.66K | -81.11%1.27M | -80.88%1.05M |
| -Other receivable | ---- | -48.09%520.06K | ---- | -27.50%712.42K | ---- | -4.25%1M | ---- | -84.28%982.66K | ---- | -80.88%1.05M |
| Advance payment | 259.27%11.79M | 40.19%1.52M | 22.29%1.11M | 190.54%1.49M | 243.13%3.28M | 23,273.12%1.09M | 2,639.43%906.95K | 1,540.98%512.61K | -47.38%956.06K | -99.51%4.65K |
| Inventories | -16.55%36.75M | -12.90%42.85M | -15.15%47.44M | -17.94%44.75M | -13.83%44.04M | -7.02%49.2M | 12.96%55.91M | 10.88%54.53M | 3.44%51.11M | 3.20%52.92M |
| Other current assets | --7.98M | --9.57M | --5.84M | --5.83M | ---- | ---- | ---- | ---- | -86.34%553.5K | 806.75%738K |
| Total current assets | 1.22%968.14M | 0.23%938.25M | -5.02%940.36M | -4.83%948.93M | -4.92%956.46M | -4.48%936.09M | -4.17%990.01M | 302.15%997.05M | 294.49%1.01B | 346.23%980.03M |
| Non Current assets | ||||||||||
| Fixed assets | ---- | 93.58%106.33M | ---- | -0.49%58.35M | ---- | -3.24%54.93M | ---- | 0.54%58.64M | ---- | -6.13%56.77M |
| Constru in process | ---- | -81.62%8.76M | ---- | 26.59%54.6M | ---- | 64.23%47.67M | ---- | 46.13%43.14M | ---- | 80.59%29.03M |
| Productive biological assets | -21.88%3.95M | -8.63%4.4M | 1.12%4.58M | 4.00%3.46M | 29.11%5.05M | 32.71%4.82M | 47.03%4.53M | 28.05%3.33M | 1.94%3.91M | 2.33%3.63M |
| Intangible assets | -2.39%23.22M | -2.35%23.41M | -1.90%23.6M | -1.86%23.79M | 1.27%23.79M | 1.37%23.97M | 1.05%24.06M | 1.13%24.24M | -3.10%23.49M | -3.51%23.65M |
| Long deferred expense | -25.67%694.64K | -24.13%754.62K | -22.75%814.61K | -21.53%874.6K | -20.43%934.58K | -19.44%994.57K | -18.54%1.05M | -17.71%1.11M | -16.96%1.17M | -16.27%1.23M |
| Deferred tax assets | 0.99%9.89M | -3.94%9.67M | 63.52%9.96M | 6.72%9.91M | 95.39%9.79M | 79.39%10.06M | 50.78%6.09M | 82.32%9.29M | -2.26%5.01M | -0.50%5.61M |
| Usufruct assets | -68.11%3.71M | -7.69%10.95M | -7.55%11.18M | -7.41%11.41M | -7.27%11.64M | -7.14%11.86M | -7.02%12.09M | -6.90%12.32M | -6.78%12.55M | -6.67%12.78M |
| Other non current assets | 0.00%22.5K | 2,058.88%14.2M | 0.00%22.5K | 2,348.00%550.8K | --22.5K | 448.31%657.97K | -97.87%22.5K | -97.87%22.5K | ---- | --120K |
| Total non current assets | 2.70%177.34M | 13.50%193.38M | 10.00%182.61M | 5.97%179.54M | 10.20%172.68M | 11.92%170.38M | 8.60%166.02M | 9.34%169.43M | 4.41%156.69M | 3.68%152.23M |
| Total assets | 1.45%1.15B | 2.27%1.13B | -2.86%1.12B | -3.26%1.13B | -2.88%1.13B | -2.28%1.11B | -2.52%1.16B | 189.53%1.17B | 187.02%1.16B | 208.98%1.13B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Notes payable and accounts payable | -46.71%2.02M | -20.07%2.25M | -24.08%3.4M | -14.96%3.64M | 9.47%3.79M | -28.83%2.81M | 12.67%4.48M | 72.84%4.28M | 6.97%3.46M | 84.07%3.95M |
| -Accounts payable | -46.71%2.02M | -20.07%2.25M | -24.08%3.4M | -14.96%3.64M | 9.47%3.79M | -28.83%2.81M | 12.67%4.48M | 72.84%4.28M | 6.97%3.46M | 84.07%3.95M |
| Contract liabilities | -20.16%2.39M | -30.05%1.81M | 317.14%2.64M | 47.33%2.93M | -15.32%3M | -26.88%2.59M | 53.73%633.36K | 38.32%1.99M | 20.64%3.54M | 38.92%3.55M |
| Salaries payable | 59.17%4.11M | 3.83%4.87M | -15.74%1.94M | -0.23%7.69M | -32.65%2.58M | 44.97%4.69M | 140.48%2.3M | 32.53%7.7M | -3.83%3.83M | -7.33%3.24M |
| Taxs payable | 153.18%6.17M | 9.18%2.51M | -56.86%1.48M | -88.74%460.64K | -70.34%2.44M | -76.91%2.3M | 14.36%3.42M | 190.86%4.09M | 26.61%8.22M | 228.19%9.97M |
| Other payable (including interest and dividends) | -2.93%6.74M | -18.92%5.72M | 69.71%7.54M | 27.78%9.43M | 1.86%6.95M | 7.59%7.05M | 24.27%4.44M | 43.35%7.38M | 21.43%6.82M | 29.42%6.55M |
| -Dividend payable | 19.39%19.7K | 12.12%18.5K | 83.33%16.5K | 83.33%16.5K | 83.33%16.5K | 83.33%16.5K | --9K | 444.46%9K | 444.46%9K | 444.46%9K |
| -Other payable | ---- | -18.99%5.7M | ---- | 27.71%9.42M | ---- | 7.49%7.03M | ---- | 43.22%7.37M | ---- | 29.28%6.54M |
| Non current liabilities due within one year | -79.04%287.82K | -43.49%775.86K | -44.76%758.43K | -44.76%758.43K | 0.00%1.37M | -5.61%1.37M | 0.00%1.37M | 3.61%1.37M | 0.00%1.37M | -29.37%1.45M |
| Other current liabilities | -6.11%71.85K | -30.05%54.4K | 680.84%97.79K | 44.97%86.39K | -2.66%76.52K | -25.17%77.76K | -73.31%12.52K | 38.32%59.59K | -10.76%78.61K | 32.31%103.91K |
| Total current liabilities | 7.91%21.8M | -13.91%17.99M | 7.17%17.85M | -7.02%24.99M | -26.08%20.2M | -27.47%20.9M | 24.98%16.65M | 52.27%26.87M | 15.18%27.33M | 56.34%28.81M |
| Current liabilities | ||||||||||
| Deferred tax liabilities | -4.10%5.33M | -4.10%5.33M | 109.94%5.45M | -4.02%5.45M | 114.34%5.56M | 114.34%5.56M | 0.00%2.59M | 118.73%5.67M | 0.00%2.59M | 0.00%2.59M |
| Lease liabilities | -65.37%4.19M | -6.57%11.81M | -0.95%12.36M | -0.89%12.2M | -5.59%12.11M | -4.51%12.64M | -5.10%12.47M | -5.46%12.31M | -4.65%12.83M | -0.09%13.24M |
| Total non current liabilities | -46.09%9.53M | -5.82%17.14M | 18.14%17.8M | -1.88%17.65M | 14.58%17.67M | 14.97%18.2M | -4.26%15.07M | 15.17%17.98M | -3.89%15.42M | -0.08%15.83M |
| Total liabilities | -17.29%31.33M | -10.14%35.13M | 12.38%35.65M | -4.96%42.63M | -11.41%37.87M | -12.42%39.1M | 9.15%31.72M | 34.86%44.86M | 7.48%42.75M | 30.26%44.64M |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%108.22M | 0.00%108.22M | 0.00%108.22M | 0.00%108.22M | 0.00%108.22M | 0.00%108.22M | 0.00%108.22M | 33.34%108.22M | 33.34%108.22M | 33.34%108.22M |
| Capital reserve funds | 0.76%878.09M | 0.76%878.09M | 0.76%878.09M | 0.76%878.09M | 0.00%871.49M | 0.00%871.49M | 0.00%871.49M | 666.99%871.49M | 666.99%871.49M | 666.99%871.49M |
| Surplus reserve funds | 10.12%45.82M | 10.12%45.82M | 10.12%45.82M | 10.12%45.82M | 18.58%41.61M | 18.58%41.61M | 18.58%41.61M | 18.58%41.61M | 26.98%35.09M | 26.98%35.09M |
| Retained profit | 17.28%82.03M | 39.77%64.38M | -46.41%55.19M | -46.45%53.71M | -33.46%69.95M | -36.75%46.06M | -27.52%102.99M | -28.22%100.31M | -26.42%105.13M | -33.66%72.82M |
| Shareholders equity without minority interests | 2.10%1.11B | 2.73%1.1B | -3.29%1.09B | -3.19%1.09B | -2.56%1.09B | -1.86%1.07B | -2.82%1.12B | 203.45%1.12B | 206.57%1.12B | 227.42%1.09B |
| Total shareholder equity | 2.10%1.11B | 2.73%1.1B | -3.29%1.09B | -3.19%1.09B | -2.56%1.09B | -1.86%1.07B | -2.82%1.12B | 203.45%1.12B | 206.57%1.12B | 227.42%1.09B |
| Total liabilityies and equity | 1.45%1.15B | 2.27%1.13B | -2.86%1.12B | -3.26%1.13B | -2.88%1.13B | -2.28%1.11B | -2.52%1.16B | 189.53%1.17B | 187.02%1.16B | 208.98%1.13B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | -- | -- | -- |
| Auditor | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
